nodes	percent_of_prediction	percent_of_DWPC	metapath
Lithium—IMPA1—renal system—nephrolithiasis	0.0753	0.119	CbGeAlD
Lithium—IMPA1—kidney—nephrolithiasis	0.0728	0.116	CbGeAlD
Lithium—IMPA2—nephron tubule—nephrolithiasis	0.0622	0.0986	CbGeAlD
Lithium—IMPA2—renal system—nephrolithiasis	0.0565	0.0897	CbGeAlD
Lithium—GSK3B—renal system—nephrolithiasis	0.0555	0.088	CbGeAlD
Lithium—IMPA2—kidney—nephrolithiasis	0.0547	0.0867	CbGeAlD
Lithium—GSK3B—kidney—nephrolithiasis	0.0536	0.085	CbGeAlD
Lithium—IMPA2—cortex of kidney—nephrolithiasis	0.0532	0.0844	CbGeAlD
Lithium—GSK3A—nephron tubule—nephrolithiasis	0.0531	0.0841	CbGeAlD
Lithium—GSK3A—renal system—nephrolithiasis	0.0482	0.0765	CbGeAlD
Lithium—GSK3A—cortex of kidney—nephrolithiasis	0.0454	0.072	CbGeAlD
Lithium—Sexual dysfunction—Hydrochlorothiazide—nephrolithiasis	0.0246	0.0688	CcSEcCtD
Lithium—Memory impairment—Hydrochlorothiazide—nephrolithiasis	0.0176	0.0492	CcSEcCtD
Lithium—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.017	0.0476	CcSEcCtD
Lithium—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.014	0.0393	CcSEcCtD
Lithium—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.0125	0.0349	CcSEcCtD
Lithium—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0319	CcSEcCtD
Lithium—Swelling—Hydrochlorothiazide—nephrolithiasis	0.0113	0.0318	CcSEcCtD
Lithium—Thirst—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0294	CcSEcCtD
Lithium—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.00941	0.0263	CcSEcCtD
Lithium—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00917	0.0257	CcSEcCtD
Lithium—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00885	0.0248	CcSEcCtD
Lithium—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00882	0.0247	CcSEcCtD
Lithium—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00796	0.0223	CcSEcCtD
Lithium—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00787	0.022	CcSEcCtD
Lithium—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.0078	0.0218	CcSEcCtD
Lithium—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00705	0.0197	CcSEcCtD
Lithium—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00645	0.0181	CcSEcCtD
Lithium—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00618	0.0173	CcSEcCtD
Lithium—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00612	0.0171	CcSEcCtD
Lithium—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00594	0.0166	CcSEcCtD
Lithium—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.0059	0.0165	CcSEcCtD
Lithium—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00568	0.0159	CcSEcCtD
Lithium—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00564	0.0158	CcSEcCtD
Lithium—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00554	0.0155	CcSEcCtD
Lithium—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00551	0.0154	CcSEcCtD
Lithium—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00541	0.0152	CcSEcCtD
Lithium—Syncope—Hydrochlorothiazide—nephrolithiasis	0.0054	0.0151	CcSEcCtD
Lithium—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.0053	0.0148	CcSEcCtD
Lithium—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00513	0.0144	CcSEcCtD
Lithium—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00507	0.0142	CcSEcCtD
Lithium—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00502	0.014	CcSEcCtD
Lithium—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00496	0.0139	CcSEcCtD
Lithium—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00492	0.0138	CcSEcCtD
Lithium—Shock—Hydrochlorothiazide—nephrolithiasis	0.00484	0.0135	CcSEcCtD
Lithium—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00469	0.0131	CcSEcCtD
Lithium—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00459	0.0129	CcSEcCtD
Lithium—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00448	0.0125	CcSEcCtD
Lithium—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00437	0.0122	CcSEcCtD
Lithium—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00433	0.0121	CcSEcCtD
Lithium—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00427	0.012	CcSEcCtD
Lithium—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00424	0.0119	CcSEcCtD
Lithium—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00405	0.0113	CcSEcCtD
Lithium—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00402	0.0113	CcSEcCtD
Lithium—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00389	0.0109	CcSEcCtD
Lithium—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00389	0.0109	CcSEcCtD
Lithium—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00353	0.00988	CcSEcCtD
Lithium—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00336	0.00942	CcSEcCtD
Lithium—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00325	0.0091	CcSEcCtD
Lithium—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00313	0.00875	CcSEcCtD
Lithium—Rash—Hydrochlorothiazide—nephrolithiasis	0.0031	0.00868	CcSEcCtD
Lithium—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.0031	0.00867	CcSEcCtD
Lithium—Headache—Hydrochlorothiazide—nephrolithiasis	0.00308	0.00863	CcSEcCtD
Lithium—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00292	0.00818	CcSEcCtD
Lithium—GSK3B—Hedgehog 'off' state—ADCY10—nephrolithiasis	0.00174	0.142	CbGpPWpGaD
Lithium—GSK3B—Signaling by Hedgehog—ADCY10—nephrolithiasis	0.00155	0.127	CbGpPWpGaD
Lithium—IMPA2—Metabolism—GRHPR—nephrolithiasis	0.00065	0.0531	CbGpPWpGaD
Lithium—IMPA2—Metabolism—AGXT—nephrolithiasis	0.00058	0.0473	CbGpPWpGaD
Lithium—IMPA1—Metabolism—GRHPR—nephrolithiasis	0.00058	0.0473	CbGpPWpGaD
Lithium—IMPA1—Metabolism—AGXT—nephrolithiasis	0.000517	0.0422	CbGpPWpGaD
Lithium—IMPA2—Metabolism—APRT—nephrolithiasis	0.000493	0.0402	CbGpPWpGaD
Lithium—IMPA2—Metabolism—SLC26A1—nephrolithiasis	0.000493	0.0402	CbGpPWpGaD
Lithium—GRIA3—BDNF signaling pathway—SPP1—nephrolithiasis	0.00046	0.0375	CbGpPWpGaD
Lithium—IMPA1—Metabolism—SLC26A1—nephrolithiasis	0.000439	0.0358	CbGpPWpGaD
Lithium—IMPA1—Metabolism—APRT—nephrolithiasis	0.000439	0.0358	CbGpPWpGaD
Lithium—IMPA2—Metabolism—AQP1—nephrolithiasis	0.000351	0.0287	CbGpPWpGaD
Lithium—IMPA2—Metabolism—CHRM3—nephrolithiasis	0.000318	0.0259	CbGpPWpGaD
Lithium—IMPA1—Metabolism—AQP1—nephrolithiasis	0.000313	0.0255	CbGpPWpGaD
Lithium—IMPA1—Metabolism—CHRM3—nephrolithiasis	0.000283	0.0231	CbGpPWpGaD
Lithium—GSK3A—Signaling by PDGF—SPP1—nephrolithiasis	0.000273	0.0223	CbGpPWpGaD
Lithium—GSK3B—BDNF signaling pathway—SPP1—nephrolithiasis	0.000244	0.0199	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—ADCY10—nephrolithiasis	0.000215	0.0175	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—SPP1—nephrolithiasis	0.000202	0.0165	CbGpPWpGaD
Lithium—GSK3A—Disease—SLC26A1—nephrolithiasis	0.000197	0.0161	CbGpPWpGaD
Lithium—GSK3B—Focal Adhesion—SPP1—nephrolithiasis	0.000195	0.0159	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—RGS14—nephrolithiasis	0.000182	0.0149	CbGpPWpGaD
Lithium—GSK3A—Disease—ATP6V0A4—nephrolithiasis	0.000176	0.0144	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ADCY10—nephrolithiasis	0.000159	0.0129	CbGpPWpGaD
Lithium—GSK3B—Disease—SLC26A1—nephrolithiasis	0.000146	0.0119	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—RGS14—nephrolithiasis	0.000135	0.011	CbGpPWpGaD
Lithium—GSK3B—Disease—ATP6V0A4—nephrolithiasis	0.00013	0.0106	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000123	0.0101	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—DGKH—nephrolithiasis	0.000123	0.0101	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ATP6V0A4—nephrolithiasis	9.11e-05	0.00743	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—DGKH—nephrolithiasis	9.11e-05	0.00743	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CHRM3—nephrolithiasis	8.91e-05	0.00727	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PTH—nephrolithiasis	8.15e-05	0.00665	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CHRM3—nephrolithiasis	6.58e-05	0.00537	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PTH—nephrolithiasis	6.02e-05	0.00491	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—SPP1—nephrolithiasis	4.09e-05	0.00334	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—SPP1—nephrolithiasis	3.02e-05	0.00247	CbGpPWpGaD
